Three-Pronged attack on breast cancer shows promise before surgery
NCT ID NCT02520063
Summary
This early-stage study tested a combination of three drugs given to postmenopausal women before breast cancer surgery. The goal was to see if the drugs—two approved and one experimental—could safely shrink tumors by attacking the cancer in different ways. Researchers enrolled 15 women with hormone-positive, HER2-negative breast cancer to find the best dose and get a first look at how well the treatment worked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.